At BPI Labs, we specialize in the development and manufacturing of high-quality sterile injectable pharmaceuticalstrusted by healthcare providers nationwide. Our broad portfolio includes essential medications used in hospitals, clinics, and specialty care settings. As an FDA-approved drug manufacturer and cGMP-certified facility, we uphold the highest standards of safety, efficacy, and compliance in every product we produce.
With state-of-the-art manufacturing capabilities, we focus on delivering reliable, high-purity injectables that meet critical patient care needs. Our commitment to quality, innovation, and regulatory excellence ensures that each batch undergoes rigorous testing before reaching the market.
BPI Labs remains dedicated to advancing healthcare by ensuring that essential medications are available when and where they’re needed most.
ABLYSINOL® is indicated to induce controlled cardiac septal infarction to improve exercise capacity in adults with symptomatic hypertrophic obstructive cardiomyopathy who are not candidates for surgical myectomy.
54288-0159-05
Container:
Prefilled Syringe
Pack Size:
5
54288-0147-01
Container:
Vial
Pack Size:
1
54288-0152-01
Container:
Vial
Pack Size:
1
54288-0120-10
Container:
Vial
Pack Size:
1
54288-0119-25
Container:
Vial
Pack Size:
25
54288-0103-10
Container:
Ampoule
Pack Size:
10
*All product information provided within this section is for intended use within the United States only. Pharmaceutical product Information on this website is intended for reference only and should not be used for prescribing or dispensing products without reference to the appropriate product prescribing information.
Copyright 2025 BPI Labs, Inc | All Rights Reserved